CD14 and neoplasm: FRβ is expressed on IL-10-producing M2-like macrophages (CD163+, CD68+, CD14+ IL-10), corresponding to the anti-inflammatory/pro-tumor TAM subtype, prompting substantial interest in depleting TAMs by exploiting FRβ on the surface of macrophages19.